Operates as an antibody discovery company.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Adimab operates as an antibody discovery company. Adimab selects high affinity antibodies that behave well in a formulation and manufacturing context. Adimab selects human antibodies with its formulation and manufacturing characteristics by integrating all aspects of antibody discovery and developing screening methods.
Adimab Funding
Sign up to gain insights into Adimab funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series E | Nov 22, 2010 | 4M | ||
| Series D | Sep 22, 2009 | 8M | ||
| Series C | Nov 25, 2008 | 4M | ||
| Series B | Mar 27, 2008 | 3M | ||
| Series A | Sep 10, 2007 | 6M | ||
| Series A | Aug 03, 2007 | 399K |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Adimab Management Team
Investors
Borealis Ventures
OrbiMed Advisors
SV Life Sciences Advisers
Polaris Partners
Adimab Valuations & Financials
View real-time NPM data on Adimab stock including daily Adimab stock price estimates, valuation history, and historical share price information. Access Adimab financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Adimab pricing across six independent market signals. Looking for private company due diligence data sources on Adimab? Get in touch to learn more.
Similar Companies
like Adimab
Cedar
Healthcare & Life Sciences
The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Virta Health
Healthcare & Life Sciences
Online specialty medical clinic focused on reversing type 2 diabetes.
Elligo Health Research
Healthcare & Life Sciences
Connects healthcare sites, sponsors, and patients to streamline clinical trial access through technology and data-driven solutions.
Droplet Biosciences
Healthcare & Life Sciences
Turning surgical drain fluid into powerful, early molecular insights to guide personalized post-surgery cancer care.
Hinge Health
Healthcare & Life Sciences
Digital clinic for back, joint, and muscle pain.
TurtleTree
Healthcare & Life Sciences
Biotech company focused on creating sustainable and innovative nutrition solutions.
Verge Genomics
Healthcare & Life Sciences
Drug discovery company that combines artificial intelligence and neuroscience.
FAQ
We have answers
Adimab stock does not trade on public stock exchanges. Adimab stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Adimab stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Adimab Stock does not trade on public stock exchanges. In order to sell Adimab shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Adimab does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Adimab share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Adimab stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Adimab stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Adimab stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Adimab is a private company and has not had an IPO. There is currently no Adimab IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Adimab IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
